Functional genomics approaches to improve pre‐clinical drug screening and biomarker discovery
Abstract Advances in sequencing technology have enabled the genomic and transcriptomic characterization of human malignancies with unprecedented detail. However, this wealth of information has been slow to translate into clinically meaningful outcomes. Different models to study human cancers have be...
Saved in:
| Main Authors: | Long V Nguyen, Carlos Caldas |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2021-07-01
|
| Series: | EMBO Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.15252/emmm.202013189 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Screening drug effects in patient‐derived cancer cells links organoid responses to genome alterations
by: Julia Jabs, et al.
Published: (2017-11-01) -
The role of genomics and proteomics in drug discovery and its application in pharmacy
by: Lakshman Kumar Dogiparthi, et al.
Published: (2025-05-01) -
Editorial: Exploring drug development with single cell omics analytics and stem cell-based disease models
by: Linheng Li, et al.
Published: (2025-02-01) -
Genome-wide associations spanning 194 in-hospital drug dosage change phenotypes highlight diverse genetic backgrounds in concurrent drug therapy
by: Alexander Pil Henriksen, et al.
Published: (2025-01-01) -
Recent advances in AI-based toxicity prediction for drug discovery
by: Hyundo Lee, et al.
Published: (2025-07-01)